These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16864049)
1. Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era. Grigg A; Hughes T Biol Blood Marrow Transplant; 2006 Aug; 12(8):795-807. PubMed ID: 16864049 [TBL] [Abstract][Full Text] [Related]
2. Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors? Maziarz RT Curr Opin Hematol; 2008 Mar; 15(2):127-33. PubMed ID: 18300759 [TBL] [Abstract][Full Text] [Related]
8. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up. Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G; Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007. Goldman J Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S11-S13. PubMed ID: 18724281 [TBL] [Abstract][Full Text] [Related]
10. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia. Cho BS; Kim HJ; Lee S; Eom KS; Min WS; Lee JW; Kim CC Eur J Haematol; 2007 Aug; 79(2):170-3. PubMed ID: 17608710 [TBL] [Abstract][Full Text] [Related]
11. [An advance in the treatment of CML]. Ohnishi K Gan To Kagaku Ryoho; 2007 Dec; 34(13):2185-90. PubMed ID: 18079618 [TBL] [Abstract][Full Text] [Related]
16. Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generation. Tanaka R; Kimura S Expert Rev Anticancer Ther; 2008 Sep; 8(9):1387-98. PubMed ID: 18759691 [TBL] [Abstract][Full Text] [Related]
17. [Stem cell transplantation in the imatinib era]. Masszi T Orv Hetil; 2005 May; 146(18 Suppl 1):900-4. PubMed ID: 15921302 [TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry. Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P; Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375 [TBL] [Abstract][Full Text] [Related]